INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 459m ago
House PTR59m ago
SEC 13F58m ago
Robinhood Chain58m ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07RJRubinstein Julie0B / 37S37 trades$6.38M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
6
PH
Perkins Abigail HChief Information Officer
SNEXStoneX Group Inc.
Option exercise · 10b5-1 plan
M$79K
4,312 sh
Jun 8, 2026Jun 9, 2026
Page 714 of 1737
← PrevNext →
traded Jun 8, 2026
+1d
SEC Form 4

Evidence

5
WT
Wettig ThaneDirector, CEO
KYNBKYNTRA BIO, INC.
Tax withholding
F$1,329
198 sh
Jun 6, 2026Jun 9, 2026
traded Jun 6, 2026
+3dSEC Form 4

Evidence

5
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Tax withholding
F$13K
319 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
RJ
Rieger JaysonDirector, CEO and President
VRCAVerrica Pharmaceuticals Inc.
Grant or award
A—
512.3K sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Other acquisition or disposition
J—
24.7K sh
Jun 8, 2026Jun 9, 2026
traded Jun 8, 2026
+1dSEC Form 4

Evidence

5
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Option exercise
M—
718 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
DS
Das SouvikChief Technology Officer
CWANClearwater Analytics Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$244K
10.0K sh
Jun 8, 2026Jun 9, 2026
traded Jun 8, 2026
+1dSEC Form 4

Evidence

5
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Tax withholding
F$34K
810 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
ZD
Zugelder DanEVP, Chief Revenue Officer
DTDynatrace, Inc.
Option exercise
M—
4,043 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
MA
McMahon Stephen AEVP, Chief Customer Officer
DTDynatrace, Inc.
Grant or award
A—
37.9K sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Grant or award
A—
8,889 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Option exercise
M—
2,409 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Tax withholding
F$11K
249 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
ZD
Zugelder DanEVP, Chief Revenue Officer
DTDynatrace, Inc.
Grant or award
A—
61.0K sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Other acquisition or disposition
J—
47.0K sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Other acquisition or disposition
J—
47.0K sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
RR
Ricker Sean RaymondChief Financial Officer
BBAIBigBear.ai Holdings, Inc.
Tax withholding
F$41K
9,759 sh
Jun 6, 2026Jun 9, 2026
traded Jun 6, 2026
+3dSEC Form 4

Evidence

5
GR
Gray Nancy RyanDirector
LGNDLIGAND PHARMACEUTICALS INC
Grant or award
A—
2,938 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
CL
CP BF Lending, LLC10% Owner
BNZIBanzai International, Inc.
Derivative conversion
C—
30.7K sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
PB
Pfeiffenberger BrentDirector, President and CEO
IPSCCentury Therapeutics, Inc.
Tax withholding
F$986
463 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
CL
CP BF Lending, LLC10% Owner
BNZIBanzai International, Inc.
Derivative conversion
C—
5,079 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Option exercise
M—
703 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Other acquisition or disposition
J—
24.7K sh
Jun 8, 2026Jun 9, 2026
traded Jun 8, 2026
+1dSEC Form 4

Evidence

5
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Option exercise
M—
560 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
AK
Akgonul Rifat KerimChief Product Officer
PEGAPEGASYSTEMS INC
Option exercise
M—
2,278 sh
Jun 7, 2026Jun 9, 2026
traded Jun 7, 2026
+2dSEC Form 4

Evidence

5
ZD
Zawitz DavidChief Operating Officer
VRCAVerrica Pharmaceuticals Inc.
Grant or award
A—
171.3K sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
NA
Novack Jeffrey AdamSecretary and General Counsel
CDNACareDx, Inc.
Tax withholding
F$28K
1,292 sh
Jun 6, 2026Jun 9, 2026
traded Jun 6, 2026
+3dSEC Form 4

Evidence

5
ZD
Zugelder DanEVP, Chief Revenue Officer
DTDynatrace, Inc.
Option exercise
M—
13.9K sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
KA
Kang AndrewEVP & CFO
MSTRStrategy Inc
Open-market sale · 10b5-1 plan
SELL$2,498
20 sh
Jun 9, 2026Jun 9, 2026
traded Jun 9, 2026
+0dSEC Form 4

Evidence

5
LL
Lamattina John LDirector
LGNDLIGAND PHARMACEUTICALS INC
Grant or award
A—
836 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Option exercise
M—
703 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Tax withholding
F$50K
1,185 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Tax withholding
F$45K
1,069 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Tax withholding
F$13K
312 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
AK
Akgonul Rifat KerimChief Product Officer
PEGAPEGASYSTEMS INC
Tax withholding
F$38K
1,102 sh
Jun 7, 2026Jun 9, 2026
traded Jun 7, 2026
+2dSEC Form 4

Evidence

5
LL
Lamattina John LDirector
LGNDLIGAND PHARMACEUTICALS INC
Grant or award
A—
2,938 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

5
AC
Amara CarmenChief People Officer
YELPYELP INC
Open-market sale · 10b5-1 plan
SELL$24K
1,000 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC Form 4

Evidence

4
GK
Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
PUBMPubMatic, Inc.
Derivative conversion · 10b5-1 plan
C—
44.0K sh
Jun 8, 2026Jun 9, 2026
traded Jun 8, 2026
+1dSEC Form 4

Evidence

3
GK
Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
PUBMPubMatic, Inc.
Option exercise · 10b5-1 plan
M$95K
44.0K sh
Jun 8, 2026Jun 9, 2026
traded Jun 8, 2026
+1dSEC Form 4

Evidence

3
KA
Kang AndrewEVP & CFO
MSTRStrategy Inc
Option exercise · 10b5-1 plan
M—
4,260 sh
Jun 8, 2026Jun 9, 2026
traded Jun 8, 2026
+1dSEC Form 4

Evidence